Genpact (G) Stock Price

Genpact Price

NYSE·CLOSED
35.33USD-1.31 (-3.64 %)
Market closed

Revenue has compounded at 11.8% per year over the past 19 years to 5.08 B USD. Earnings per share have grown at 6.2% per year over the last 19 years. Genpact's net margin stands at 10.9%, up from 9.2% several years earlier. Genpact currently offers a dividend yield of about 1.92%. The payout ratio is around 22% of earnings. Analysts set a median price target of 53.55 USD, implying 51.6% above the current price. Of 20 analysts, 11 rate the stock a buy — an overall Buy consensus. The stock trades about 28% above its 52-week low.

Genpact stock price

Volume
Ex-Dividend
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of Genpact over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Genpact stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Genpact's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Genpact Stock Price History
DateGenpact Price
7/30/202635.33 USD
7/29/202636.64 USD
7/27/202632.39 USD
7/23/202630.37 USD
7/22/202630.01 USD
7/21/202630.18 USD
7/20/202630.64 USD
7/17/202630.89 USD
7/16/202631.22 USD
7/15/202630.07 USD
7/14/202629.52 USD
7/13/202630.44 USD
7/10/202629.37 USD
7/9/202629.64 USD
7/8/202629.59 USD
7/7/202629.74 USD
7/6/202629.02 USD
7/2/202629.10 USD
7/1/202628.26 USD
6/30/202627.50 USD
6/29/202627.99 USD
6/26/202628.53 USD
6/25/202627.67 USD
6/24/202628.53 USD
6/23/202628.28 USD
6/22/202628.11 USD
6/18/202628.25 USD
6/17/202630.31 USD
6/16/202631.32 USD
6/15/202631.00 USD
6/12/202632.06 USD
6/11/202631.89 USD
6/10/202632.19 USD
6/5/202632.62 USD
6/4/202632.86 USD
6/3/202632.30 USD
6/2/202632.84 USD
6/1/202634.45 USD
5/29/202632.95 USD
5/28/202632.42 USD
5/27/202631.58 USD
5/26/202631.19 USD
5/22/202631.91 USD
5/21/202632.00 USD
5/20/202632.12 USD
5/14/202628.94 USD
5/13/202629.44 USD
5/4/202634.14 USD
5/1/202634.33 USD
4/30/202634.75 USD
4/29/202633.88 USD
4/28/202633.95 USD
4/27/202633.83 USD
4/24/202634.32 USD
4/23/202634.50 USD
4/22/202636.22 USD
4/21/202637.03 USD
4/20/202636.64 USD
4/17/202636.93 USD
4/16/202636.63 USD
4/15/202636.24 USD
4/14/202635.50 USD
4/13/202635.54 USD
4/10/202634.18 USD
4/9/202635.54 USD
4/8/202636.93 USD
4/7/202637.49 USD
4/6/202637.60 USD
4/2/202637.84 USD
4/1/202637.23 USD
3/31/202637.25 USD
3/30/202637.45 USD
3/27/202636.60 USD
3/26/202637.41 USD
3/25/202637.66 USD
3/24/202637.82 USD
3/23/202638.71 USD
3/20/202638.70 USD
3/19/202638.31 USD
3/18/202638.31 USD
3/17/202638.34 USD
3/16/202638.28 USD
3/13/202638.30 USD
3/12/202638.15 USD
3/11/202638.75 USD
3/10/202638.93 USD
3/9/202640.86 USD
3/6/202641.70 USD
3/5/202641.68 USD
3/4/202640.78 USD
3/3/202640.36 USD
3/2/202640.21 USD
2/27/202639.72 USD
2/26/202638.75 USD
2/25/202637.81 USD
2/24/202637.94 USD
2/23/202637.54 USD
2/20/202638.93 USD
2/19/202638.86 USD
2/18/202639.18 USD
2/17/202637.73 USD
2/13/202637.36 USD
2/12/202636.31 USD
2/11/202637.18 USD
2/10/202639.14 USD
2/9/202639.49 USD
2/6/202640.39 USD
2/5/202638.51 USD
2/4/202638.34 USD
2/3/202638.97 USD
2/2/202644.13 USD
1/30/202644.10 USD
1/29/202644.61 USD
1/28/202644.78 USD
1/27/202645.27 USD
1/26/202645.48 USD
1/23/202645.80 USD
1/22/202646.19 USD
1/21/202645.73 USD
1/20/202644.77 USD
1/16/202645.91 USD
1/15/202646.22 USD
1/14/202647.44 USD
1/13/202646.52 USD
1/12/202647.13 USD
1/9/202648.24 USD
1/8/202647.62 USD
1/7/202647.40 USD
1/6/202647.35 USD
1/5/202646.60 USD
1/2/202645.91 USD
12/31/202546.78 USD
12/30/202547.18 USD
12/29/202547.89 USD
12/26/202548.05 USD
12/24/202548.09 USD
12/23/202548.13 USD
12/22/202548.50 USD
12/19/202547.91 USD
12/18/202547.73 USD
12/17/202547.95 USD
12/16/202547.77 USD
12/15/202547.35 USD
12/12/202547.79 USD
12/11/202547.36 USD
12/10/202546.36 USD
12/9/202545.61 USD
12/8/202546.22 USD
12/5/202546.37 USD
12/4/202546.01 USD
12/3/202545.31 USD
12/2/202544.06 USD
12/1/202544.19 USD
11/28/202544.06 USD
11/26/202544.21 USD
11/25/202544.64 USD
11/24/202544.08 USD
11/21/202544.36 USD
11/20/202543.73 USD
11/19/202543.92 USD
11/18/202543.80 USD
11/17/202543.74 USD
11/14/202544.89 USD
11/13/202545.05 USD
11/12/202545.54 USD
11/11/202544.89 USD
11/10/202544.27 USD
11/7/202544.49 USD
11/6/202541.45 USD
11/5/202538.82 USD
11/4/202538.43 USD
11/3/202538.12 USD
10/31/202538.15 USD
10/30/202538.12 USD
10/29/202537.89 USD
10/28/202539.21 USD
10/27/202539.51 USD
10/24/202539.78 USD
10/23/202539.78 USD
10/22/202539.78 USD
10/21/202540.29 USD
10/20/202539.86 USD
10/17/202539.51 USD
10/16/202538.95 USD
10/15/202539.42 USD
10/14/202539.86 USD
10/13/202539.52 USD
10/10/202539.31 USD
10/9/202540.18 USD
10/8/202540.67 USD
10/7/202540.70 USD
10/6/202541.11 USD
10/3/202541.35 USD
10/2/202541.40 USD
10/1/202541.84 USD
9/30/202541.89 USD
9/29/202542.17 USD
9/28/202542.17 USD
9/25/202542.21 USD
9/24/202541.79 USD
9/23/202541.06 USD
9/22/202541.15 USD
9/19/202541.13 USD
9/18/202541.30 USD
9/17/202541.77 USD
9/16/202541.33 USD
9/15/202542.11 USD
9/12/202542.56 USD
9/11/202543.33 USD
9/10/202543.00 USD
9/9/202543.69 USD
9/8/202544.27 USD
9/5/202545.02 USD
9/4/202544.97 USD
9/3/202545.20 USD
9/2/202544.89 USD
8/29/202545.13 USD
8/28/202544.97 USD
8/27/202545.41 USD
8/26/202545.10 USD
8/25/202545.45 USD
8/22/202545.21 USD
8/21/202544.52 USD
8/20/202544.04 USD
8/19/202544.79 USD
8/18/202544.07 USD
8/15/202543.77 USD
8/14/202543.70 USD
8/13/202544.22 USD
8/12/202543.31 USD
8/11/202543.25 USD
8/8/202544.02 USD
8/7/202541.72 USD
8/6/202542.20 USD
8/5/202542.37 USD
8/4/202542.55 USD
Access this data via the Eulerpool API

Genpact Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
4.02 B USD
509.00 M USD
369.45 M USD
Jan 1, 2022
4.37 B USD
502.15 M USD
353.40 M USD
Jan 1, 2023
4.48 B USD
630.86 M USD
631.26 M USD
Jan 1, 2024
4.77 B USD
702.06 M USD
513.67 M USD
Jan 1, 2025
5.08 B USD
760.01 M USD
552.49 M USD
Jan 1, 2026 (e)
5.43 B USD
778.05 M USD
719.50 M USD
Jan 1, 2027 (e)
5.83 B USD
835.09 M USD
791.56 M USD
Jan 1, 2028 (e)
6.32 B USD
904.95 M USD
905.50 M USD

Genpact Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 2, 2026, 2:19 AM
 
REVENUEB USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
DIV.USD
DIV. GROWTH%
SHARESM
20132014201520162017201820192020202120222023202420252026e2027e2028e
2.132.282.462.572.743.003.523.714.024.374.484.775.085.435.836.32
12.156.897.994.436.469.6517.335.378.448.682.406.506.546.997.348.37
38.0939.5339.2939.5338.5635.9734.8034.8135.5835.1435.0835.4535.5635.5635.5635.56
0.810.900.971.021.061.081.231.291.431.541.571.691.811.932.072.25
309.00294.00334.00341.00331.00385.00429.00438.00508.00502.00630.00702.00760.00778.00835.00904.00
14.4912.9013.5713.2712.1012.8312.1911.8112.6311.4814.0814.7314.9614.3214.3214.30
235.00192.00239.00267.00260.00281.00304.00308.00369.00353.00631.00513.00552.00719.00791.00905.00
27.72-18.3024.4811.72-2.628.088.191.3219.81-4.3478.75-18.707.6030.2510.0114.41
0.240.300.340.390.430.500.550.610.680.750.840.94
25.0013.3314.7110.2616.2810.0010.9111.4810.2912.0011.90
230.06216.47215.68203.43196.86193.15196.59194.82193.19187.53183.35180.44174.99174.99174.99174.99
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Genpact generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Genpact retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Genpact's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Genpact has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Genpact's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Genpact stock margins

The Genpact margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Genpact. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Genpact.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
35.60 %
12.65 %
9.19 %
Jan 1, 2022
35.15 %
11.49 %
8.08 %
Jan 1, 2023
35.08 %
14.09 %
14.10 %
Jan 1, 2024
35.45 %
14.73 %
10.78 %
Jan 1, 2025
35.57 %
14.96 %
10.88 %
Jan 1, 2026 (e)
35.57 %
14.32 %
13.24 %
Jan 1, 2027 (e)
35.57 %
14.32 %
13.57 %
Jan 1, 2028 (e)
35.57 %
14.32 %
14.33 %

Genpact Stock Revenue, EBIT, Earnings per Share

The Genpact earnings per share therefore indicates how much revenue Genpact has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
20.82 USD
2.63 USD
1.91 USD
Jan 1, 2022
23.31 USD
2.68 USD
1.88 USD
Jan 1, 2023
24.42 USD
3.44 USD
3.44 USD
Jan 1, 2024
26.42 USD
3.89 USD
2.85 USD
Jan 1, 2025
29.03 USD
4.34 USD
3.16 USD
Jan 1, 2026 (e)
30.77 USD
4.45 USD
4.07 USD
Jan 1, 2027 (e)
33.02 USD
4.77 USD
4.48 USD
Jan 1, 2028 (e)
35.78 USD
5.17 USD
5.13 USD

Genpact business model & stock analysis

Genpact Ltd is a global company that offers outsourcing and consulting services. It was founded in 1997 and is headquartered in Bermuda. Genpact is a leading provider in process optimization and digitalization, with over 110,000 employees in more than 30 countries worldwide. The company offers a wide range of services.

Genpact SWOT Analysis

Strengths

Genpact Ltd possesses several strengths that contribute to its competitive advantage and success in the market:

  • Strong market position and brand recognition.
  • Extensive industry knowledge and expertise.
  • Global presence and diversified customer base.
  • Robust technology infrastructure.
  • Wide range of services and solutions offered.
  • Strong relationships with strategic partners.

Despite its strengths, Genpact Ltd also faces certain weaknesses that could hinder its growth and performance:

  • Dependence on key clients for a significant portion of revenue.
  • Vulnerability to economic fluctuations and market uncertainties.
  • Integration challenges resulting from mergers and acquisitions.
  • Limited diversification in terms of industry sectors served.
  • Highly competitive market landscape.

Genpact Ltd can leverage the following opportunities to further expand and enhance its business operations:

  • Increased adoption of digital technologies and automation.
  • Emerging markets with untapped potential for outsourcing services.
  • Growing demand for analytics and data-driven decision-making.
  • Expansion into new industry sectors and service lines.
  • Strategic partnerships and collaborations.

Genpact Ltd should be aware of the following threats that might affect its business operations and market position:

  • Intense competition from both established and emerging players.
  • Regulatory changes and compliance requirements.
  • Rapid technological advancements requiring continuous innovation.
  • Economic downturns impacting client spending and investment decisions.
  • Challenges related to talent acquisition and retention.

Weaknesses

Despite its strengths, Genpact Ltd also faces certain weaknesses that could hinder its growth and performance:

  • Dependence on key clients for a significant portion of revenue.
  • Vulnerability to economic fluctuations and market uncertainties.
  • Integration challenges resulting from mergers and acquisitions.
  • Limited diversification in terms of industry sectors served.
  • Highly competitive market landscape.

Genpact Ltd can leverage the following opportunities to further expand and enhance its business operations:

  • Increased adoption of digital technologies and automation.
  • Emerging markets with untapped potential for outsourcing services.
  • Growing demand for analytics and data-driven decision-making.
  • Expansion into new industry sectors and service lines.
  • Strategic partnerships and collaborations.

Genpact Ltd should be aware of the following threats that might affect its business operations and market position:

  • Intense competition from both established and emerging players.
  • Regulatory changes and compliance requirements.
  • Rapid technological advancements requiring continuous innovation.
  • Economic downturns impacting client spending and investment decisions.
  • Challenges related to talent acquisition and retention.

Opportunities

Genpact Ltd can leverage the following opportunities to further expand and enhance its business operations:

  • Increased adoption of digital technologies and automation.
  • Emerging markets with untapped potential for outsourcing services.
  • Growing demand for analytics and data-driven decision-making.
  • Expansion into new industry sectors and service lines.
  • Strategic partnerships and collaborations.

Genpact Ltd should be aware of the following threats that might affect its business operations and market position:

  • Intense competition from both established and emerging players.
  • Regulatory changes and compliance requirements.
  • Rapid technological advancements requiring continuous innovation.
  • Economic downturns impacting client spending and investment decisions.
  • Challenges related to talent acquisition and retention.

Threats

Genpact Ltd should be aware of the following threats that might affect its business operations and market position:

  • Intense competition from both established and emerging players.
  • Regulatory changes and compliance requirements.
  • Rapid technological advancements requiring continuous innovation.
  • Economic downturns impacting client spending and investment decisions.
  • Challenges related to talent acquisition and retention.

Genpact Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Genpact Employees
Details
Date
Genpact Employees
Jan 1, 2018
- Employees
Jan 1, 2019
- Employees
Jan 1, 2020
- Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees

Genpact Segments

Genpact Revenue by Segment (1/2)

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Details
Date
Core Business Services
Business Process Services
Digital Operations
Data-Tech-AI
Advanced Technology Solutions
Information Technology Services
Jan 1, 2014
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2015
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2016
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2017
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD

Genpact Revenue by Segment (2/2)

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

Business Process Services
Information Technology Services
Details
Date
Business Process Services
Information Technology Services
Jan 1, 2014
1.74 B USD
542.72 M USD
Jan 1, 2015
1.93 B USD
527.95 M USD
Jan 1, 2016
2.08 B USD
487.31 M USD
Jan 1, 2017
2.26 B USD
472.59 M USD

Genpact Revenue by Region

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

India
Banking, Financial Services And Insurance
Manufacturing and Pharmaceuticals
Asia, other than India
North and Latin America
Technology, Healthcare and Others
Europe
Americas
Details
Date
India
Banking, Financial Services And Insurance
Manufacturing and Pharmaceuticals
Asia, other than India
North and Latin America
Technology, Healthcare and Others
Europe
Americas
Jan 1, 2018
1.74 B USD
0.00 USD
0.00 USD
327.46 M USD
641.72 M USD
0.00 USD
292.16 M USD
0.00 USD
Jan 1, 2019
1.89 B USD
0.00 USD
0.00 USD
356.73 M USD
863.75 M USD
0.00 USD
409.17 M USD
0.00 USD
Jan 1, 2020
1.85 B USD
0.00 USD
0.00 USD
461.84 M USD
1.01 B USD
0.00 USD
388.56 M USD
0.00 USD
Jan 1, 2021
2.02 B USD
0.00 USD
0.00 USD
536.60 M USD
1.01 B USD
0.00 USD
451.73 M USD
0.00 USD
Jan 1, 2022
2.28 B USD
0.00 USD
0.00 USD
551.47 M USD
1.07 B USD
0.00 USD
471.48 M USD
0.00 USD
Jan 1, 2023
2.32 B USD
0.00 USD
0.00 USD
643.10 M USD
979.95 M USD
0.00 USD
532.99 M USD
0.00 USD
Jan 1, 2024
2.76 B USD
0.00 USD
0.00 USD
700.26 M USD
683.41 M USD
0.00 USD
621.92 M USD
0.00 USD
Jan 1, 2025
2.98 B USD
0.00 USD
0.00 USD
788.06 M USD
730.44 M USD
0.00 USD
578.40 M USD
0.00 USD

Genpact Eulerpool Fair Value

Details

Fair Value Estimate

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Genpact historical P/E ratio, EBIT multiple, and P/S ratio

Genpact annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Genpact shares outstanding

The number of shares of Genpact was 174.99 M in 2025. This indicates how many shares Genpact is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
193.19 M Stocks
Jan 1, 2022
187.53 M Stocks
Jan 1, 2023
183.35 M Stocks
Jan 1, 2024
180.44 M Stocks
Jan 1, 2025
174.99 M Stocks
Jan 1, 2026 (e)
174.99 M Stocks
Jan 1, 2027 (e)
174.99 M Stocks
Jan 1, 2028 (e)
174.99 M Stocks

Genpact Dividend History

11 years of dividend payments · 8 consecutive increases

YearAnnual DividendYoY ChangePayments
20260.19USDYTD
Mar 16, 20260.19USD 10.3%1/1
20250.68USD 11.5%
Mar 11, 20250.17USD 11.5%1/4
Jun 18, 20250.17USD 0.0%2/4
Sep 11, 20250.17USD 0.0%3/4
Dec 9, 20250.17USD 0.0%4/4
20240.61USD 10.9%
20230.55USD 10.0%
20220.50USD 16.3%
20210.43USD 10.3%
20200.39USD 14.7%
20190.34USD 13.3%
20180.30USD 25.0%
20170.24USD 89.3%

Genpact dividend history and estimates

In 2025, Genpact paid a dividend amounting to 0.68 USD. Dividend means that Genpact distributes a portion of its profits to its owners.
  • Max

Dividend
Dividend (Estimate)
Special dividend
Details
Date
Dividend
Dividend (Estimate)
Special dividend
Jan 1, 2021
0.43 USD
0.00 USD
0.00 USD
Jan 1, 2022
0.50 USD
0.00 USD
2.24 USD
Jan 1, 2023
0.55 USD
0.00 USD
0.00 USD
Jan 1, 2024
0.61 USD
0.00 USD
0.00 USD
Jan 1, 2025
0.68 USD
0.00 USD
0.00 USD
Jan 1, 2026 (e)
0.19 USD
0.56 USD
0.00 USD
Jan 1, 2027 (e)
0.00 USD
0.84 USD
0.00 USD
Jan 1, 2028 (e)
0.00 USD
0.94 USD
0.00 USD

Genpact dividend payout ratio

In 2025, Genpact had a payout ratio of 21.54%. The payout ratio indicates the percentage of the company's profits that Genpact distributes as dividends.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
22.49 %
Jan 1, 2022
26.53 %
Jan 1, 2023
15.98 %
Jan 1, 2024
21.43 %
Jan 1, 2025
21.54 %
Jan 1, 2026 (e)
18.41 %
Jan 1, 2027 (e)
18.71 %
Jan 1, 2028 (e)
18.27 %

Current Genpact forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
55.00 % (11)
Hold
45.00 % (9)
Sell
0.00 % (0)
12M Price Target
53.55
Last Price
35.17
Currency
USD
12M Return Potential
52.26 %
LTM Return
0 %

Genpact Analyst Rating Actions

DateFirmActionRating
7/9/2026
TD Cowen
TD Cowen
MaintainedBuy
7/7/2026
Baird
Baird
MaintainedNeutral
5/11/2026
Mizuho
Mizuho
MaintainedNeutral
5/11/2026
Citigroup
Citigroup
MaintainedNeutral
5/11/2026
Baird
Baird
MaintainedNeutral
5/8/2026
Needham
Needham
MaintainedBuy
5/5/2026
Susquehanna
Susquehanna
MaintainedNeutral
2/10/2026
Mizuho
Mizuho
MaintainedNeutral
2/6/2026
Needham
Needham
MaintainedBuy
8/20/2025
JP Morgan
JP Morgan
MaintainedNeutral

Genpact Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
8/6/20260.98USD1.36 BUSD2026 Q2
5/7/20260.94USD1.32 BUSD2026 Q1
2/5/20260.95USD1.33 BUSD2025 Q4
5/8/20240.73USD1.14 BUSD2024 Q1
2/7/20240.75USD1.14 BUSD2023 Q4
11/7/20230.81USD1.22 BUSD2023 Q3
8/2/20230.75USD1.18 BUSD2023 Q2
5/3/20230.68USD1.13 BUSD2023 Q1
2/9/20230.70USD1.10 BUSD2022 Q4
11/9/20220.70USD1.10 BUSD2022 Q3

EESG©

Eulerpool ESG Scorecard© for the Genpact stock

96/100
99
Environment
99
Social
91
Governance
E

Environment

20
Scope 1 - Direct Emissions3,989
Scope 2 - Indirect emissions from purchased energy41,248
Scope 3 - Indirect emissions within the value chain82,629
Total CO₂ emissions45,237
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees42.522
Percentage of women in management
Percentage of Asian employees27.72
Share of Asian management
Percentage of Hispanic/Latino employees7.86
Hispano/Latino Management share
Percentage of Black employees24.64
Black Management Share
Percentage of white employees36.36
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Genpact shareholder structure

% Name
11.25937%
FMR LLC
FMR LLC
8.50977%
BLACKROCK, INC.
BLACKROCK, INC.
7.75701%
NALANDA INDIA EQUITY FUND LTD
NALANDA INDIA EQUITY FUND LTD
6.38486%
AQR CAPITAL MANAGEMENT LLC
AQR CAPITAL MANAGEMENT LLC
4.89286%
VANGUARD PORTFOLIO MANAGEMENT LLC
VANGUARD PORTFOLIO MANAGEMENT LLC
4.22195%
VANGUARD CAPITAL MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC
...

Genpact Beneficial Ownership Filings (SEC 13D/G)

Free Float
90.9%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
15.10%
Gates Capital Management, Inc.
Gates Capital Management, Inc.
SEC ↗
14.09%
Abigail P. Johnson
Abigail P. Johnson
SEC ↗
12.06%
04-2683227
04-2683227
SEC ↗
11.40%
FMR LLC
FMR LLC
SEC ↗
11.24%
Wellington Management Group LLP
Wellington Management Group LLP
SEC ↗
9.00%
BlackRock, Inc.
BlackRock, Inc.
SEC ↗
8.81%
The Vanguard Group - 23-1945930
The Vanguard Group - 23-1945930
SEC ↗
6.94%
Nalanda India Equity Fund Limited
Nalanda India Equity Fund Limited
SEC ↗
6.64%
AQR Capital Management, LLC
AQR Capital Management, LLC
SEC ↗
6.37%
Brown Advisory Incorporated ("BA, Inc.")
Brown Advisory Incorporated ("BA, Inc.")
SEC ↗

Genpact Executives and Management Board

BK

Mr. Balkrishan Kalra

(55)

President, Chief Executive Officer, Director · since 2008

Compensation10.88 M USD
MW

Mr. Michael Weiner

(53)

Chief Financial Officer, Senior Vice President

Compensation6.45 M USD
RV

Ms. Riju Vashisht

(57)

Senior Vice President, Chief Growth Officer and Global Business Leader, Enterprise Services and Partnerships & Alliances

Compensation5.96 M USD
PM

Mr. Piyush Mehta

(56)

Senior Vice President, Chief Human Resources Officer and Country Manager, India

Compensation5.91 M USD
AN

Mr. Anil Nanduru

(50)

Senior Vice President, Global Business Leader, High Tech & Manufacturing and Consumer & Healthcare

Compensation5.86 M USD

Frequently asked questions about Genpact

The business model of Genpact Ltd is focused on providing digital transformation services to various industries. As a global professional services firm, Genpact leverages its expertise in data analytics, technology, and process optimization to help businesses streamline operations, enhance customer experiences, and drive growth. By combining its deep domain knowledge with advanced technologies like artificial intelligence and automation, Genpact enables organizations to improve efficiency, reduce costs, and stay competitive in today's rapidly evolving market. Genpact's business model revolves around delivering innovative solutions and strategic insights that empower its clients to stay ahead in the digital age.

All fundamentals and in-depth analysis of Genpact

Our stock analysis for Genpact stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genpact. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.